Covid-19 — Baricitinib Compared to Standard Therapy in Patients With COVID-19
Citation(s)
BARICIVID-19 STUDY: MultiCentre, Randomised, Phase IIa Clinical Trial Evaluating Efficacy and Tolerability of Baricitinib as add-on Treatment of In-patients With COVID-19 Compared to Standard Therapy